Last update 17 Dec 2025

TQH2929

Overview

Basic Info

Drug Type
Biological products
Synonyms
TQH 2929, TQH-2929, TQH2929
Target-
Action-
Mechanism-
Therapeutic Areas
Immune System DiseasesSkin and Musculoskeletal DiseasesOther Diseases
Active Indication
Generalized Pustular PsoriasisPsoriasis
Inactive Indication-
Originator Organization
Nanjing Shunxin Pharmaceutical Co., Ltd.Nanjing Shunxin Pharmaceutical Co., Ltd.
Active Organization
Nanjing Shunxin Pharmaceutical Co., Ltd.Nanjing Shunxin Pharmaceutical Co., Ltd.Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with TQH2929
NCT06433531
/ Active, not recruitingPhase 1
Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Efficacy of TQH2929 in Healthy Adult Subjects and Psoriasis Subjects
NCT06156280
/ CompletedPhase 1
Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Efficacy of TQH2929 in Healthy Adult Subjects
CTR20233339
/ CompletedPhase 1
评价TQH2929在健康成人受试者及银屑病受试者中的安全性、耐受性、药代动力学特征和药效的Ⅰ期临床试验
[Translation] Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics and efficacy of TQH2929 in healthy adult subjects and subjects with psoriasis
100 Clinical Results associated with TQH2929
Login to view more data
100 Translational Medicine associated with TQH2929
Login to view more data
100 Patents (Medical) associated with TQH2929
Login to view more data
100 Deals associated with TQH2929
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Generalized Pustular PsoriasisPhase 2
China
Nanjing Shunxin Pharmaceutical Co., Ltd.Nanjing Shunxin Pharmaceutical Co., Ltd.
17 Dec 2025
PsoriasisPhase 1
China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
21 Nov 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free